Profound Medical Book Value Per Share Growth & History (PROF)
Profound Medical's book value per share was $1.83 for fiscal 2025.
View full Profound Medical company overviewProfound Medical annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.83 | -$0.18 | −9.00% |
| 2024 | 2024-12-31 | $2.01 | $0.55 | +37.67% |
| 2023 | 2023-12-31 | $1.46 | -$1.06 | −42.00% |
| 2022 | 2022-12-31 | $2.52 | -$1.36 | −35.08% |
| 2021 | 2021-12-31 | $3.88 | -$0.94 | −19.45% |
| 2020 | 2020-12-31 | $4.82 | $3.60 | +297.31% |
| 2019 | 2019-12-31 | $1.21 | -$0.61 | −33.29% |
| 2018 | 2018-12-31 | $1.82 | — | — |
Profound Medical quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.36 | $0.06 | +4.37% |
| Q1 2026 | 2026-03-31 | $1.64 | -$0.05 | −3.24% |
| Q4 2025 | 2025-12-31 | $1.83 | -$0.18 | −9.00% |
| Q3 2025 | 2025-09-30 | $1.06 | — | — |
| Q2 2025 | 2025-06-30 | $1.31 | — | — |
| Q1 2025 | 2025-03-31 | $1.69 | — | — |
| Q4 2024 | 2024-12-31 | $2.01 | $0.55 | +37.67% |
| Q4 2023 | 2023-12-31 | $1.46 | -$1.06 | −42.00% |
| Q4 2022 | 2022-12-31 | $2.52 | -$1.36 | −35.08% |
| Q4 2021 | 2021-12-31 | $3.88 | -$0.94 | −19.45% |
| Q4 2020 | 2020-12-31 | $4.82 | $3.60 | +297.31% |
| Q4 2019 | 2019-12-31 | $1.21 | — | — |
Profound Medical book value per share trends
Over the last five fiscal years, Profound Medical's book value per share decreased from $4.82 to $1.83, a change of -$2.99. The latest reported quarter, Q2 2026, shows $1.36.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Profound Medical source filings ↗